Pediatric Low-grade Glioma
2 clinical trials · Condition
◉ Watch Pediatric Low-grade Glioma
| Record | Firm | Date |
|---|---|---|
| Phase 1/2 Study of Mirdametinib + Vinblastine for Newly Diagnosed/Previously Untreated PLGG + Activation of MAPK (NCT06666348) | St. Justine's Hospital | 2026-01-12 |
| DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2) (NCT05566795) | Day One Biopharmaceuticals, Inc. | 2023-02-27 |
Track Pediatric Low-grade Glioma automatically
Every clearance here is in the API, with alerts when new ones post.